Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SMAD4 anticorps

L’anticorps anti-SMAD4 Monoclonal Souris est utilisé pour la détection de SMAD4 dans des échantillons de Humain. Il a été validé pour IHC.
N° du produit ABIN7126665
687,58 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour SMAD4 anticorps (ABIN7126665)

Antigène

Voir toutes SMAD4 Anticorps
SMAD4 (SMAD Family Member 4 (SMAD4))

Reactivité

  • 141
  • 62
  • 55
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 102
  • 39
  • 1
  • 1
Souris

Clonalité

  • 80
  • 63
Monoclonal

Conjugué

  • 98
  • 8
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp SMAD4 est non-conjugé

Application

  • 75
  • 56
  • 45
  • 33
  • 24
  • 22
  • 18
  • 7
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

SMAD4-2440
  • Fonction

    SMAD4 (Pancreatic Adenocarcinoma Marker) Antibody

    Specificité

    Signaling from the ligand-activated membrane receptor serine/threonine kinases to nuclear targets is mediated by a set of evolutionarily conserved proteins known as DPC4. Upon ligand binding, the receptors of the TGF- æ family phosphorylate SMAD proteins (SMAD1 and SMAD2). These proteins then move into the nucleus, where they activate transcription. To carry out this function, the receptor activated SMAD1 and 2 require association with the product of deleted in pancreatic carcinoma, locus 4 (DPC4), also known as SMAD4. SMAD4/DPC4 is also implicated as a tumor suppressor, since it is inactivated in more than half of pancreatic carcinomas and to a lesser extent in a variety of other cancers. SMAD4 is absent in approximately 80 % of pancreatic adenocarcinoma, but rarely in endometrial, colorectal, ovarian, lung, breast adenocarcinomas, and malignant melanom. SMAD4 is an important marker for confirming a diagnosis of pancreatic adenocarcinoma. Patients with pancreatic adenocarcinomas with SMAD4 protein expression had significantly longer survival than SMAD4 negative patients.

    Réactivité croisée (Details)

    Human.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant full-length human STAT6 protein

    Isotype

    IgG2a, kappa
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Jurkat or A431 cells. Pancreatic Carcinoma

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    SMAD4 (SMAD Family Member 4 (SMAD4))

    Autre désignation

    SMAD4

    Sujet

    Deleted in Pancreatic Carcinoma 4 (DPC4), JIP, MAD homolog 4 (MADH4), Mothers against decapentaplegic homolog 4 (MADH4), Mothers against DPP homolog 4, MYHRS, SMAD4

    Jurkat or A431 cells. Pancreatic Carcinoma

    Poids moléculaire

    61kDa

    ID gène

    4089, 75862

    UniProt

    Q13485

    Pathways

    Cycle Cellulaire, Chromatin Binding, Autophagy
Vous êtes ici:
Chat with us!